Pulmonary function and long-term survival in patients with PERDS after autologous hematopoietic stem cell transplantation

Bone Marrow Transplant. 2023 Nov;58(11):1289-1291. doi: 10.1038/s41409-023-02101-5. Epub 2023 Aug 31.

Authors

Zhenmei Zhang¹, Patrick M Wieruszewski², Mehrdad Hefazi Torghabeh³, William J Hogan³, Hemang Yadav⁴

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA. zhang.zhenmei@mayo.edu.
² Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
³ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
⁴ Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

PMID: 37653053
PMCID: PMC10799238 (available on 2024-09-01)
DOI: 10.1038/s41409-023-02101-5

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Retrospective Studies
Transplantation, Autologous

Grants and funding

K23 HL151671/HL/NHLBI NIH HHS/United States